OverviewSuggest Edit
ResMed develops, manufactures and distributes medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. It offers a number of products for sleep-disordered breathing and other respiratory disorders including airflow generators, diagnostic products, mask systems, headgear and other accessories.
| Type | Public | |
| Founded | 1989 | |
| HQ | San Diego, CA, US | Map |
| Website | resmed.com | |
| Employee Ratings | More | |
| Overall Culture | A+ | More |
Recent NewsAll News
- Europe Continuous Positive Airway Pressure (CPAP) Devices Market Is Set to Experience Revolutionary Growth by 2027: Cardinal Health Inc, Smith’s Group plc, ResMed, 3B Medical Inc, Airing
- Pulmonary Devices Market To Witness Huge Growth By 2027 with CAGR of 10.3% | ResMed, Masimo, Invacare Corporation, Koninklijke Philips N.V., Getinge AB
- Portable Breathing Machine Market – Current Impact to Make Big Changes | Inogen, Resmed, Medtronic, GE Healthcare
- Global Adult Ventilators Market Report 2020 Top Companies- Philips Healthcare, ResMed, Medtronic, Becton, Dickinson, Getinge, Dräger and more...
Key People/Management at ResMed
Michael Mick Farrell
CEO
Rob Douglas
President and Chief Operating Officer
David Pendarvis
Chief Administrative Officer, Global General Counsel
Jim Hollingshead
President, Sleep Business
McHale Richie
Chief Transformation Officer
Raj Sodhi
President, SaaS Business
ResMed Office Locations
ResMed has offices in San Diego, Alexandria, Rochester, Bella Vista and in 24 other locations
San Diego, CA, US (HQ)
9001 Spectrum Center Blvd
Alexandria, VA, US
Alexandria, VA, USA
Rochester, NY, US
1200 Brooks Ave
Bella Vista, AU
1 Elizabeth Macarthur Dr
Kontich, BE
50 Grote Steenweg
Beijing, CN
24 Dong San Huan Zhong Lu
ResMed Financials and Metrics
ResMed Revenue
ResMed's revenue was reported to be $2.96 b in FY, 2020
| USD | |
|---|---|
Revenue (Q1, 2021) | 751.9m |
Gross profit (Q1, 2021) | 438.7m |
Gross profit margin (Q1, 2021), % | 58.3% |
Net income (Q1, 2021) | 178.4m |
EBIT (Q1, 2021) | 216.9m |
Market capitalization (15-Jan-2021) | 30.7b |
Closing stock price (15-Jan-2021) | 211.6 |
Cash (30-Sept-2020) | 421.4m |
EV | 31.4b |
ResMed's current market capitalization is $30.7 b.
Annual
Quarterly
| USD | Q1, 2011 | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 282.0m | 306.0m | 313.3m | 314.8m | 332.7m | 349.1m | 339.7m | 376.5m | 383.6m | 357.7m | 384.3m | 397.8m | 380.4m | 423.0m | 422.5m | 411.6m | 454.5m | 453.9m | 465.5m | 530.4m | 514.2m | 523.7m | 601.3m | 591.6m | 588.3m | 651.1m | 662.2m | 681.1m | 736.2m | 769.5m | 751.9m |
Cost of goods sold | 108.1m | 120.0m | 130.8m | 129.7m | 134.0m | 138.6m | 131.1m | 143.8m | 144.1m | 129.7m | 135.6m | 146.0m | 143.1m | 159.7m | 171.1m | 173.0m | 188.0m | 194.0m | 196.3m | 221.3m | 214.5m | 218.1m | 251.5m | 247.3m | 245.2m | 267.4m | 270.3m | 276.0m | 309.0m | 319.8m | 313.3m |
Gross profit | 174.0m | 186.0m | 182.5m | 185.1m | 198.7m | 210.5m | 208.6m | 232.7m | 239.4m | 228.0m | 248.8m | 251.8m | 237.3m | 263.2m | 251.4m | 238.6m | 266.5m | 259.9m | 269.2m | 309.1m | 299.7m | 305.6m | 349.8m | 344.3m | 343.1m | 383.7m | 391.9m | 405.1m | 427.1m | 449.7m | 438.7m |
Gross profit Margin, % | 62% | 61% | 58% | 59% | 60% | 60% | 61% | 62% | 62% | 64% | 65% | 63% | 62% | 62% | 60% | 58% | 59% | 57% | 58% | 58% | 58% | 58% | 58% | 58% | 58% | 59% | 59% | 59% | 58% | 58% | 58% |
Annual
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash | 735.3m | 809.5m | 876.0m | 905.7m | 717.2m | 731.4m | 821.9m | 188.7m | 147.1m | 463.2m |
Accounts Receivable | 274.4m | 283.2m | 318.3m | 359.6m | 362.6m | 450.5m | 483.7m | 528.5m | 474.6m | |
Prepaid Expenses | 58.9m | 72.2m | 61.1m | 78.7m | 81.2m | 103.2m | 124.6m | 120.1m | 168.7m | |
Inventories | 200.8m | 174.4m | 145.8m | 165.4m | 246.9m | 224.5m | 268.3m | 268.7m | 349.6m | 416.9m |
Quarterly
Annual
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 227.0m | 254.9m | 307.1m | 345.3m | 352.9m | 352.4m | 342.3m | 315.6m | 404.6m | 621.7m |
Depreciation and Amortization | 70.6m | 85.9m | 78.3m | 73.5m | 73.1m | 86.8m | 112.2m | 120.0m | 150.8m | 154.9m |
Inventories | 11.4m | 18.8m | 27.1m | (15.9m) | (99.5m) | 30.5m | (41.6m) | 1.5m | (84.2m) | (69.9m) |
Accounts Payable | (12.8m) | 72.8m | 29.6m | 3.1m | 85.8m | 46.4m | 34.6m | 200.7m | (27.3m) | (23.4m) |
Quarterly
| USD | Q1, 2011 |
|---|---|
Financial Leverage | 1.2 x |
ResMed Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Propeller Health | December 07, 2018 | |
| MatrixCare Inc | November 05, 2018 | $750 m |
ResMed Cybersecurity Score
ResMed Environment, Social & Governance (ESG) Ratings
ResMed Online and Social Media Presence
7.74k Twitter followers
ResMed has 7.74k Twitter Followers. The number of followers has decreased 0.2% month over month and increased 0.3% quarter over quarter
ResMed's Trends
Twitter Engagement Stats for @ResMed
3.8k
Tweets
982
Following
7.7k
Followers
6
Tweets last 30 days
1.8
Avg. likes per Tweet
33.3%
Tweets with engagement
ResMed Company Culture
Overall Culture
A+
87/100
CEO Rating
A+
99/100
Compensation
A+
93/100
Diversity
A
79/100
ResMed News and Updates
November 25, 2020
Europe Continuous Positive Airway Pressure (CPAP) Devices Market Is Set to Experience Revolutionary Growth by 2027: Cardinal Health Inc, Smith’s Group plc, ResMed, 3B Medical Inc, Airing
The Europe continuous positive airway pressure (CPAP) devices market is expected to reach US$ 1,034.76 million by 2027 from US$ 588.66 million in 2019. The market is expected to grow with a CAGR of 7.4% from 2020 to 2027. Posted via Industry Today. Follow us on Twitter @IndustryToday
October 27, 2020
Pulmonary Devices Market To Witness Huge Growth By 2027 with CAGR of 10.3% | ResMed, Masimo, Invacare Corporation, Koninklijke Philips N.V., Getinge AB
The North America pulmonary devices market is expected to reach US$ 16,637.44 million by 2027 from US$ 7,581.04 million in 2019. The market is anticipated to grow at a CAGR of 10.3% during 2019–2027. Posted via Industry Today. Follow us on Twitter @IndustryToday
July 30, 2020
Portable Breathing Machine Market – Current Impact to Make Big Changes | Inogen, Resmed, Medtronic, GE Healthcare
Stay up-to-date with Global Portable Breathing Machine Market research offered by AMA. Check how key trends and emerging drivers are shaping this industry growth. Posted via Industry Today. Follow us on Twitter @IndustryToday
July 28, 2020
Global Adult Ventilators Market Report 2020 Top Companies- Philips Healthcare, ResMed, Medtronic, Becton, Dickinson, Getinge, Dräger and more...
A new market study, titled “Global Adult Ventilators Market Professional Survey Report 2020”, has been featured on WiseGuyReports. Posted via Industry Today. Follow us on Twitter @IndustryToday
April 02, 2020
Tesla could help make batteries for ventilators to help fight COVID-19, says ResMed CEO
Amid a COVID-19 pandemic and ventilator shortage, Tesla purchased 1,000 "non-invasive ventilators" made by ResMed to donate to hospitals, explained CEO Mick Farrell. Typically, higher-end ventilators are recommended to treat patients.
August 13, 2019
Global Sleep Apnea Diagnostic and Therapeutic Devices Market Report 2019-2024 with 50+ Profiles of Key Players Including Fisher and Paykel, Philips Respironics, ResMed
DUBLIN, Aug. 13, 2019 /PRNewswire/ -- The "Sleep Apnea Diagnostic and Therapeutic Devices - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe,...
ResMed Blogs
October 07, 2019
Cerner and ResMed Join Forces to Connect Health Networks and the Home
Two industry leaders collaborate to improve out-of-hospital care transitions and chronic disease management
September 24, 2019
ResMed Named 2019 Dealmaker of the Year by Medtech Insight
5 key acquisitions drove global connected health leader’s award win
ResMed Frequently Asked Questions
When was ResMed founded?
ResMed was founded in 1989.
Who are ResMed key executives?
ResMed's key executives are Michael Mick Farrell, Rob Douglas and David Pendarvis.
How many employees does ResMed have?
ResMed has 7,240 employees.
What is ResMed revenue?
Latest ResMed annual revenue is $3 b.
What is ResMed revenue per employee?
Latest ResMed revenue per employee is $408.4 k.
Who are ResMed competitors?
Competitors of ResMed include Dentsply Sirona, Medizone International and Intersect ENT.
Where is ResMed headquarters?
ResMed headquarters is located at 9001 Spectrum Center Blvd, San Diego.
Where are ResMed offices?
ResMed has offices in San Diego, Alexandria, Rochester, Bella Vista and in 24 other locations.
How many offices does ResMed have?
ResMed has 28 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies